Search research articles
Contact Us
Filters
Showing results (231-240 of 283) with videos related to
Page
of 29
Sort By:
Cancer Immunology, Immunotherapy : CII
|
February 16, 2023
Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy
Mingjia Li, Songzhu Zhao, Gabrielle Lopez, et al.
Journal for Immunotherapy of Cancer
|
May 9, 2019
Correction to: Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T-cell immunity
Elena E Tchekneva, Mounika U L Goruganthu, Roman V Uzhachenko, et al.
Journal for Immunotherapy of Cancer
|
April 4, 2019
Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T cell immunity
Elena E Tchekneva, Mounika U L Goruganthu, Roman V Uzhachenko, et al.
Journal of Geriatric Oncology
|
August 22, 2024
Resiliency among older adults receiving lung cancer treatment (ROAR-LCT): A novel supportive care intervention for older adults with advanced lung cancer
Carolyn J Presley, Madison Grogan, Amy Compston, et al.
Cancer Research
|
April 14, 2011
Lung cancer diagnosis from proteomic analysis of preinvasive lesions
S M Jamshedur Rahman, Adriana L Gonzalez, Ming Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 19, 2018
Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET-Rearranged Lung Cancers
Alexander Drilon, Jessica J Lin, Thomas Filleron, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 7, 2023
Association Between Pretreatment Chest Imaging and Immune Checkpoint Inhibitor Pneumonitis Among Patients With Lung Cancer
Alexander Wong, Maria Riley, Songzhu Zhao, et al.
Nature Communications
|
August 12, 2018
Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC
Rajeswara Rao Arasada, Konstantin Shilo, Tadaaki Yamada, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 6, 2024
Long-Term Survival Outcomes With First-Line Nivolumab Plus Ipilimumab-Based Treatment in Patients With Metastatic NSCLC and Tumor Programmed Death-Ligand 1 Lower Than 1%: A Pooled Analysis
Solange Peters, Luis G Paz-Ares, Martin Reck, et al.
Cell Death Discovery
|
April 13, 2025
An in vivo "turning model" reveals new RanBP9 interactions in lung macrophages
Yasuko Kajimura, Shuxin Dong, Anna Tessari, et al.
Page
of 29
Search research articles
Search
Showing results (231-240 of 283) with videos related to
Sort By:
Page
of 29
Cancer Immunology, Immunotherapy : CII
|
February 16, 2023
Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy
Mingjia Li, Songzhu Zhao, Gabrielle Lopez, et al.
Journal for Immunotherapy of Cancer
|
May 9, 2019
Correction to: Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T-cell immunity
Elena E Tchekneva, Mounika U L Goruganthu, Roman V Uzhachenko, et al.
Journal for Immunotherapy of Cancer
|
April 4, 2019
Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T cell immunity
Elena E Tchekneva, Mounika U L Goruganthu, Roman V Uzhachenko, et al.
Journal of Geriatric Oncology
|
August 22, 2024
Resiliency among older adults receiving lung cancer treatment (ROAR-LCT): A novel supportive care intervention for older adults with advanced lung cancer
Carolyn J Presley, Madison Grogan, Amy Compston, et al.
Cancer Research
|
April 14, 2011
Lung cancer diagnosis from proteomic analysis of preinvasive lesions
S M Jamshedur Rahman, Adriana L Gonzalez, Ming Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 19, 2018
Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET-Rearranged Lung Cancers
Alexander Drilon, Jessica J Lin, Thomas Filleron, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 7, 2023
Association Between Pretreatment Chest Imaging and Immune Checkpoint Inhibitor Pneumonitis Among Patients With Lung Cancer
Alexander Wong, Maria Riley, Songzhu Zhao, et al.
Nature Communications
|
August 12, 2018
Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC
Rajeswara Rao Arasada, Konstantin Shilo, Tadaaki Yamada, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 6, 2024
Long-Term Survival Outcomes With First-Line Nivolumab Plus Ipilimumab-Based Treatment in Patients With Metastatic NSCLC and Tumor Programmed Death-Ligand 1 Lower Than 1%: A Pooled Analysis
Solange Peters, Luis G Paz-Ares, Martin Reck, et al.
Cell Death Discovery
|
April 13, 2025
An in vivo "turning model" reveals new RanBP9 interactions in lung macrophages
Yasuko Kajimura, Shuxin Dong, Anna Tessari, et al.
Page
of 29